
Precipio PRPO
$ 29.8
-6.14%
Annual report 2025
added 03-30-2026
Precipio P/B Ratio 2011-2026 | PRPO
Annual P/B Ratio Precipio
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.63 | 2.9 | 0.603 | 0.0473 | 1.31 | 3.22 | 0.832 | 0.688 | 0.41 | -0.833 | -0.615 | 4.28 | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 4.28 | -0.833 | 1.29 |
P/B Ratio of other stocks in the Diagnostics research industry
| Issuer | P/B Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Akumin
AKU
|
0.532 | - | -17.87 % | $ 25.9 M | ||
|
Centogene N.V.
CNTG
|
1.47 | - | -6.23 % | $ 30.6 M | ||
|
Agilent Technologies
A
|
7.78 | $ 110.97 | -3.4 % | $ 33.7 B | ||
|
Castle Biosciences
CSTL
|
1.56 | $ 23.96 | -3.0 % | $ 666 M | ||
|
Accelerate Diagnostics
AXDX
|
-1.81 | - | -61.36 % | $ 2.46 M | ||
|
Aspira Women's Health
AWH
|
6.75 | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
0.67 | - | -13.05 % | $ 7.29 M | ||
|
Chembio Diagnostics
CEMI
|
0.707 | - | 0.22 % | $ 16.8 M | ||
|
Neogen Corporation
NEOG
|
0.492 | $ 9.07 | -2.94 % | $ 1.97 B | ||
|
Check-Cap Ltd.
CHEK
|
-2.99 | - | - | $ 9.42 M | ||
|
Co-Diagnostics
CODX
|
0.284 | $ 1.53 | -6.13 % | $ 2.04 M | ||
|
Koninklijke Philips N.V.
PHG
|
0.995 | $ 25.62 | -5.6 % | $ 20 B | ||
|
Personalis
PSNL
|
1.25 | $ 5.05 | -8.27 % | $ 299 M | ||
|
CareDx, Inc
CDNA
|
3.28 | $ 20.44 | -6.71 % | $ 1.09 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
1.97 | - | - | $ 562 M | ||
|
DermTech
DMTK
|
0.742 | - | -11.32 % | $ 2.94 M | ||
|
Enzo Biochem
ENZ
|
0.00103 | - | -8.98 % | $ 14.8 K | ||
|
Exact Sciences Corporation
EXAS
|
8.12 | - | - | $ 19.8 B | ||
|
Fulgent Genetics
FLGT
|
0.413 | $ 14.79 | -3.33 % | $ 447 M | ||
|
Illumina
ILMN
|
2.6 | $ 120.84 | -4.79 % | $ 19.2 B | ||
|
Global Cord Blood Corporation
CO
|
0.0498 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
3.46 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
561 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
1.28 | - | 0.12 % | $ 80.1 M | ||
|
Charles River Laboratories International
CRL
|
2.4 | $ 163.54 | -1.9 % | $ 8.11 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
5.32 | - | - | $ 10.7 B | ||
|
Trinity Biotech plc
TRIB
|
-375 | $ 0.61 | -1.26 % | $ 61.9 M | ||
|
HTG Molecular Diagnostics
HTGM
|
0.554 | - | -20.0 % | $ 1.06 M | ||
|
Twist Bioscience Corporation
TWST
|
3.31 | $ 56.8 | -3.97 % | $ 3.4 B | ||
|
Guardant Health
GH
|
-135 | $ 82.48 | -0.77 % | $ 10.3 B | ||
|
Lantheus Holdings
LNTH
|
4.7 | $ 81.06 | -2.98 % | $ 5.47 B | ||
|
Heska Corporation
HSKA
|
2 | - | - | $ 1.31 B | ||
|
Interpace Biosciences
IDXG
|
0.328 | $ 1.99 | 2.9 % | $ 8.8 M | ||
|
Senseonics Holdings
SENS
|
5.74 | $ 6.44 | -10.31 % | $ 269 M | ||
|
QIAGEN N.V.
QGEN
|
1.84 | - | - | $ 10.6 B | ||
|
Medpace Holdings
MEDP
|
28.2 | $ 411.04 | 0.31 % | $ 11.9 B | ||
|
Biomerica
BMRA
|
1.75 | $ 2.16 | -1.22 % | $ 4.96 M | ||
|
Motus GI Holdings
MOTS
|
0.368 | - | -34.28 % | $ 263 K | ||
|
ICON Public Limited Company
ICLR
|
1.74 | $ 116.7 | 13.86 % | $ 9.63 B | ||
|
Laboratory Corporation of America Holdings
LH
|
2.77 | $ 256.03 | -1.35 % | $ 21.3 B | ||
|
NeoGenomics
NEO
|
1.77 | $ 8.98 | -0.5 % | $ 1.15 B | ||
|
Celcuity
CELC
|
53.4 | $ 118.45 | -1.35 % | $ 5.54 B | ||
|
National Research Corporation
NRC
|
22.5 | $ 16.04 | -4.78 % | $ 359 M | ||
|
Myriad Genetics
MYGN
|
1.11 | $ 4.68 | -3.41 % | $ 433 M | ||
|
Natera
NTRA
|
7.52 | $ 195.12 | -2.52 % | $ 19.2 B | ||
|
Quest Diagnostics Incorporated
DGX
|
1.44 | $ 189.26 | -2.93 % | $ 21 B | ||
|
Invitae Corporation
NVTA
|
5.02 | - | - | $ 21.2 M | ||
|
Burning Rock Biotech Limited
BNR
|
1.22 | $ 16.55 | -0.6 % | $ 178 M | ||
|
OpGen
OPGN
|
1.24 | - | -16.95 % | $ 1.54 M | ||
|
Organovo Holdings
ONVO
|
0.296 | - | -2.3 % | $ 19.4 M |